Qing Song Health Co.,Ltd. (TPEX: 6931)
Taiwan
· Delayed Price · Currency is TWD
100.00
0.00 (0.00%)
Dec 19, 2024, 2:23 PM CST
Qing Song Health Co.,Ltd. Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Revenue | 960.65 | 868.66 | 636.69 | 357.54 | 240.24 | 124.5 |
Revenue Growth (YoY) | 17.10% | 36.43% | 78.08% | 48.83% | 92.97% | - |
Cost of Revenue | 831.79 | 753.65 | 571.12 | 330.73 | 185.13 | 79.18 |
Gross Profit | 128.86 | 115.02 | 65.57 | 26.81 | 55.11 | 45.32 |
Selling, General & Admin | 71.71 | 61.11 | 51.66 | 31.54 | 22.72 | 14.68 |
Research & Development | - | - | - | - | 3.18 | 8.54 |
Other Operating Expenses | 0.01 | 0.08 | -0.41 | -0.72 | 0.33 | - |
Operating Expenses | 71.78 | 61.5 | 51.25 | 30.79 | 26.26 | 23.22 |
Operating Income | 57.08 | 53.52 | 14.32 | -3.98 | 28.85 | 22.1 |
Interest Expense | -21.97 | -17.64 | -14 | -11.3 | -11.21 | -9.45 |
Interest & Investment Income | 4.06 | 3.16 | 0.8 | 0.59 | 0.67 | 0.23 |
Earnings From Equity Investments | - | - | - | -0.16 | -0.23 | -0.27 |
Other Non Operating Income (Expenses) | 32.54 | 37.37 | 26.5 | 12.99 | 3.24 | 3.25 |
EBT Excluding Unusual Items | 71.71 | 76.42 | 27.61 | -1.87 | 21.33 | 15.85 |
Gain (Loss) on Sale of Investments | 1.43 | 3.69 | -1.05 | 0.04 | - | - |
Gain (Loss) on Sale of Assets | -0.77 | -0.97 | -0.29 | 0.01 | 0.1 | - |
Other Unusual Items | - | - | 1.22 | 1.46 | 1.03 | - |
Pretax Income | 72.36 | 79.14 | 27.5 | -0.36 | 22.46 | 15.85 |
Income Tax Expense | 23.08 | 20.31 | 8.98 | -0.58 | 6.44 | 3.35 |
Earnings From Continuing Operations | 49.29 | 58.83 | 18.52 | 0.22 | 16.01 | 12.5 |
Minority Interest in Earnings | -0.28 | 0.57 | 4.81 | -2.18 | -0.17 | 0.31 |
Net Income | 49.01 | 59.4 | 23.33 | -1.97 | 15.84 | 12.8 |
Net Income to Common | 49.01 | 59.4 | 23.33 | -1.97 | 15.84 | 12.8 |
Net Income Growth | 14.44% | 154.61% | - | - | 23.73% | - |
Shares Outstanding (Basic) | 60 | 60 | 60 | 60 | 52 | 36 |
Shares Outstanding (Diluted) | 60 | 60 | 60 | 60 | 52 | 36 |
Shares Change (YoY) | 0.00% | 0.01% | 0.01% | 15.91% | 44.86% | - |
EPS (Basic) | 0.82 | 0.99 | 0.39 | -0.03 | 0.31 | 0.36 |
EPS (Diluted) | 0.82 | 0.99 | 0.39 | -0.04 | 0.31 | 0.36 |
EPS Growth | 14.93% | 156.24% | - | - | -14.33% | - |
Free Cash Flow | 50.92 | -23.16 | 34.85 | 13.83 | -60.18 | 38.91 |
Free Cash Flow Per Share | 0.85 | -0.39 | 0.58 | 0.23 | -1.16 | 1.09 |
Dividend Per Share | 0.083 | 0.083 | - | - | - | - |
Gross Margin | 13.41% | 13.24% | 10.30% | 7.50% | 22.94% | 36.40% |
Operating Margin | 5.94% | 6.16% | 2.25% | -1.11% | 12.01% | 17.75% |
Profit Margin | 5.10% | 6.84% | 3.66% | -0.55% | 6.59% | 10.28% |
Free Cash Flow Margin | 5.30% | -2.67% | 5.47% | 3.87% | -25.05% | 31.25% |
EBITDA | 118.83 | 109.43 | 67.77 | 38.37 | 47.81 | 38.75 |
EBITDA Margin | 12.37% | 12.60% | 10.64% | 10.73% | 19.90% | 31.12% |
D&A For EBITDA | 61.75 | 55.91 | 53.45 | 42.35 | 18.95 | 16.65 |
EBIT | 57.08 | 53.52 | 14.32 | -3.98 | 28.85 | 22.1 |
EBIT Margin | 5.94% | 6.16% | 2.25% | -1.11% | 12.01% | 17.75% |
Effective Tax Rate | 31.89% | 25.66% | 32.64% | - | 28.69% | 21.16% |
Source: S&P Capital IQ. Standard template. Financial Sources.